title: Angiotensin-converting enzyme inhibitors and higher erythropoietin requirement in chronic haemodialysis patients.
authors.affiliation: Nephrology Department, University Hospital, Gent, Belgium.
authors.forename: A W
authors.initials: AW
authors.lastname: Dhondt
authors.forename: R C
authors.initials: RC
authors.lastname: Vanholder
authors.forename: S M
authors.initials: SM
authors.lastname: Ringoir
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D001772:Blood Cell Count; D003430:Cross-Sectional Studies; D004333:Drug Administration Routes; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D004921:Erythropoietin